Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Review of the history and current status of cell-transplant approaches for the management of neuropathic pain.

Eaton MJ, Berrocal Y, Wolfe SQ, Widerström-Noga E.

Pain Res Treat. 2012;2012:263972. doi: 10.1155/2012/263972. Epub 2012 Jun 14.

2.
3.

Cell therapy for neuropathic pain in spinal cord injuries.

Eaton M.

Expert Opin Biol Ther. 2004 Dec;4(12):1861-9. Review.

PMID:
15571449
4.

Spinal cord stimulation for neuropathic pain: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(4):1-78. Epub 2005 Mar 1.

5.

Cell and molecular approaches to the attenuation of pain after spinal cord injury.

Eaton MJ.

J Neurotrauma. 2006 Mar-Apr;23(3-4):549-59. Review.

PMID:
16629636
7.

Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous).

Attal N, Mazaltarine G, Perrouin-Verbe B, Albert T; SOFMER French Society for Physical Medicine and Rehabilitation.

Ann Phys Rehabil Med. 2009 Mar;52(2):124-41. doi: 10.1016/j.rehab.2008.12.011. Epub 2009 Feb 21.

8.

Subarachnoid transplant of a human neuronal cell line attenuates chronic allodynia and hyperalgesia after excitotoxic spinal cord injury in the rat.

Eaton MJ, Wolfe SQ, Martinez M, Hernandez M, Furst C, Huang J, Frydel BR, Gómez-Marín O.

J Pain. 2007 Jan;8(1):33-50.

PMID:
17207742
9.

Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance.

Wen YR, Tan PH, Cheng JK, Liu YC, Ji RR.

J Formos Med Assoc. 2011 Aug;110(8):487-94. doi: 10.1016/S0929-6646(11)60074-0. Review.

10.

Central Neuropathic Pain in Spinal Cord Injury.

Lee S, Zhao X, Hatch M, Chun S, Chang E.

Crit Rev Phys Rehabil Med. 2013;25(3-4):159-172.

11.

Neuropathic Pain and Spinal Cord Injury: Phenotypes and Pharmacological Management.

Widerström-Noga E.

Drugs. 2017 Jun;77(9):967-984. doi: 10.1007/s40265-017-0747-8. Review.

PMID:
28451808
12.

Current challenges and future prospects in management of neuropathic pain.

Jain KK.

Expert Rev Neurother. 2008 Nov;8(11):1743-56. doi: 10.1586/14737175.8.11.1743. Review.

PMID:
18986244
13.

Lumbar transplant of neurons genetically modified to secrete galanin reverse pain-like behaviors after partial sciatic nerve injury.

Eaton MJ, Karmally S, Martinez MA, Plunkett JA, Lopez T, Cejas PJ.

J Peripher Nerv Syst. 1999;4(3-4):245-57.

PMID:
10642092
14.

Reducing and eliminating neuropathic pain.

Santiago-Figueroa J, Kuffler DP.

P R Health Sci J. 2009 Dec;28(4):289-300. Review.

PMID:
19999236
15.

Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury.

Levendoglu F, Ogün CO, Ozerbil O, Ogün TC, Ugurlu H.

Spine (Phila Pa 1976). 2004 Apr 1;29(7):743-51.

PMID:
15087796
16.

Management of Neuropathic Pain Associated with Spinal Cord Injury.

Hagen EM, Rekand T.

Pain Ther. 2015 Jun;4(1):51-65. doi: 10.1007/s40122-015-0033-y. Epub 2015 Mar 6.

17.

Subarachnoid transplantation of immortalized galanin-overexpressing astrocytes attenuates chronic neuropathic pain.

An K, Xu Y, Yang H, Shu HH, Xiang HB, Tian YK.

Eur J Pain. 2010 Jul;14(6):595-601. doi: 10.1016/j.ejpain.2009.10.015. Epub 2009 Dec 9.

PMID:
20004601
18.

Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation.

Simpson EL, Duenas A, Holmes MW, Papaioannou D, Chilcott J.

Health Technol Assess. 2009 Mar;13(17):iii, ix-x, 1-154. doi: 10.3310/hta13170. Review.

19.

Guidance on the management of pain in older people.

Abdulla A, Adams N, Bone M, Elliott AM, Gaffin J, Jones D, Knaggs R, Martin D, Sampson L, Schofield P; British Geriatric Society.

Age Ageing. 2013 Mar;42 Suppl 1:i1-57. doi: 10.1093/ageing/afs200. Review.

PMID:
23420266
20.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626

Supplemental Content

Support Center